BioNexus Gene Lab Debt to Equity Ratio 2019-2023 | BGLC
BioNexus Gene Lab Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-12-31 | $0.00B | $0.01B | 0.18 |
2023-09-30 | $0.00B | $0.01B | 0.18 |
2023-06-30 | $0.00B | $0.01B | 0.32 |
2023-03-31 | $0.00B | $0.01B | 0.25 |
2022-12-31 | $0.00B | $0.01B | 0.31 |
2022-09-30 | $0.00B | $0.01B | 0.21 |
2022-06-30 | $0.00B | $0.01B | 0.23 |
2022-03-31 | $0.00B | $0.01B | 0.29 |
2021-12-31 | $0.00B | $0.01B | 0.33 |
2021-09-30 | $0.00B | $0.01B | 0.39 |
2021-06-30 | $0.00B | $0.01B | 0.39 |
2021-03-31 | $0.00B | $0.01B | 0.46 |
2020-12-31 | $0.00B | $0.01B | 0.52 |
2020-09-30 | $0.00B | $0.00B | 0.09 |
2020-06-30 | $0.00B | $0.00B | 0.09 |
2020-03-31 | $0.00B | $0.00B | 0.09 |
2019-12-31 | $0.00B | $0.00B | 0.10 |
2019-09-30 | $0.00B | $0.00B | 0.06 |
2019-06-30 | $0.00B | $0.00B | 0.09 |
2019-03-31 | $0.00B | $0.00B | 0.09 |
2018-12-31 | $0.00B | $0.00B | 0.09 |
2018-09-30 | $0.00B | $0.00B | 0.00 |
2018-06-30 | $0.00B | $0.00B | 0.00 |
2018-03-31 | $0.00B | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.011B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $125.431B | 15.74 |
Cencora (COR) | United States | $47.828B | 19.09 |
ICON (ICLR) | Ireland | $24.755B | 23.37 |
DiDi Global (DIDIY) | China | $23.950B | 0.00 |
Avantor (AVTR) | United States | $17.059B | 23.50 |
Viatris (VTRS) | United States | $13.760B | 3.93 |
CochLear (CHEOY) | $13.446B | 0.00 | |
Revvity (RVTY) | United States | $12.611B | 21.95 |
Medpace Holdings (MEDP) | United States | $12.076B | 39.73 |
Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
Natera (NTRA) | United States | $11.158B | 0.00 |
Solventum (SOLV) | United States | $10.666B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.782B | 50.67 |
Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
Organon (OGN) | United States | $4.709B | 4.56 |
Doximity (DOCS) | United States | $4.401B | 32.76 |
PACS (PACS) | United States | $3.643B | 0.00 |
Sotera Health (SHC) | United States | $3.204B | 15.72 |
Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
Progyny (PGNY) | United States | $3.124B | 52.42 |
GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
Life Times (LTH) | United States | $2.776B | 30.67 |
Premier (PINC) | United States | $2.493B | 9.13 |
Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
Agilon Health (AGL) | United States | $2.109B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
Agiliti (AGTI) | United States | $1.366B | 22.31 |
Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
Pediatrix Medical (MD) | United States | $0.748B | 7.74 |
Embecta (EMBC) | United States | $0.599B | 3.95 |
Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
Enhabit (EHAB) | United States | $0.495B | 44.86 |
COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
LifeMD (LFMD) | United States | $0.437B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
Beauty Health (SKIN) | United States | $0.378B | 0.00 |
MultiPlan (MPLN) | United States | $0.368B | 0.00 |
DocGo (DCGO) | United States | $0.364B | 58.17 |
ModivCare (MODV) | United States | $0.340B | 4.51 |
Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
Sharecare (SHCR) | United States | $0.266B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.123B | 41.33 |
Oncology Institute (TOI) | United States | $0.088B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.032B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
DermTech (DMTK) | United States | $0.020B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |